Search
for
Sort by
Research 91–120 of 1000+
- Polycystic Ovary Syndrome: A Common Reproductive and Metabolic Disorder Necessitating Early Recognition and Treatment
- Guidelines for the prevention of lower extremity arterial ulcers
- Repositioning Old Drugs for New Battles: The Expanding Role of Drug Repurposing in Cancer, Inflammation, and Metabolic Disease.
- Subclinical Atherosclerosis in Alopecia Areata: Usefulness of Arterial Ultrasound for Disease Diagnosis and Analysis of Its Relationship with Cardiometabolic Parameters
- Androgenic alopecia and its association with metabolic syndrome
- Mitochondrial dysfunction in metabolic syndrome and inflammatory skin disease
- Prehyperuricemia: New Milestone in Metabolic Disorders
- Editor’s picks January 2021
- A MODERN VIEW OF THE POLYCYSTIC OVARIAN SYNDROME
- Early onset androgenic alopecia in males, a marker for metabolic syndrome? A case control study
- Polycystic Ovary Syndrome
- The Role of Hormones in Hidradenitis Suppurativa: A Systematic Review
- Optimal Management of Plaque Psoriasis in Adolescents: Current Perspectives
- PMON281 PERSISTENT VIRILIZATION AND VASOMOTOR SYMPTOMS IN A TRANSMAN 5-YEARS POST TESTOSTERONE WITHDRAWAL
- Cardiovascular and Metabolic Risk Profiles Across Different Phenotypes of Polycystic Ovary Syndrome
- Screening for diabetes in women with polycystic ovary syndrome
- Cardiovascular risk factors and co-morbidities in patients with Alopecia Areata: A case-control study
- Screening guidelines for thyroid function in children with alopecia areata
- A Thallium-Based Screening Procedure to Identify Molecules That Modulate the Activity of Ca2+-Activated Monovalent Cation-Selective Channels
- Beyond Hormones: A Systematic Review of the Risk of Cardiovascular Diseases in Polycystic Ovary Syndrome
- Health Promotion Potential of Vegetables Cultivated in Northern Thailand: A Preliminary Screening of Tannin and Flavonoid Contents, 5α-Reductase Inhibition, Astringent Activity, and Antioxidant Activities
- Elevated fasting insulin is associated with cardiovascular and metabolic risk in women with polycystic ovary syndrome
- Cardiodermatology: the heart of the connection between the skin and cardiovascular disease
- Efectos de la disminución de los depósitos tisulares de hierro sobre los factores de riesgo cardiovascular en pacientes con hiperandrogenismo ovárico funcional
- Metabolic risk in PCOS: phenotype and adiposity impact
- Nonalcoholic fatty liver disease and polycystic ovary syndrome
- Endocrine care of transpeople part I. A review of cross-sex hormonal treatments, outcomes and adverse effects in transmen
- Effects of 5-alpha reductase inhibitors
- Cardiovascular risk in patients with scarring and nonscarring alopecias: Assessing the current state of evidence
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome